These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31336472)

  • 81. Therapeutic Role of Tangshenkang Granule () in Rat Model with Diabetic Nephropathy.
    Hu SJ; Shu B; Jin H; Li XF; Mao JR; Ren KJ; Gao L; Yang L; Wu YW; Wang YJ
    Chin J Integr Med; 2018 Aug; 24(8):600-605. PubMed ID: 27778266
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A Pre-Post Study of Vitamin D Supplement Effects on Urinary Megalin: The Emerging Predictive Role of Megalin in Diabetic Nephropathy Progression.
    Kasabri V; Akour A; Bulatova N; Suyagh M; Yousef AM; Al Hawari H; Al Shelleh S; Bzour J; Fahmawi H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1552-1557. PubMed ID: 32448110
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
    Bessa SS; Hussein TA; Morad MA; Amer AM
    Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
    Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
    Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Relation of Copeptin with Diabetic and Renal Function Markers Among Patients with Diabetes Mellitus Progressing Towards Diabetic Nephropathy.
    Noor T; Hanif F; Kiran Z; Rehman R; Khan MT; Haque Z; Nankani K
    Arch Med Res; 2020 Aug; 51(6):548-555. PubMed ID: 32505416
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.
    Nasser M; Ibrahim KMF; Elnabawi WM; Ahmed TM
    Egypt J Immunol; 2020 Jun; 27(2):81-92. PubMed ID: 33548980
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluation of serum adiponectin levels in diabetic nephropathy.
    Alnaggar ARLR; Sayed M; El-Deena KE; Gomaa M; Hamed Y
    Diabetes Metab Syndr; 2019; 13(1):128-131. PubMed ID: 30641684
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus.
    Metwalley KA; Farghaly HS; Gabri MF; Abdel-Aziz SM; Ismail AM; Raafat DM; Elnakeeb IF
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):293-299. PubMed ID: 33565751
    [TBL] [Abstract][Full Text] [Related]  

  • 89. SH3YL1 protein as a novel biomarker for diabetic nephropathy in type 2 diabetes mellitus.
    Choi GS; Min HS; Cha JJ; Lee JE; Ghee JY; Yoo JA; Kim KT; Kang YS; Han SY; Bae YS; Lee SR; Yoo JY; Moon SH; Lee SJ; Cha DR
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):498-505. PubMed ID: 33223406
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Association of serum leptin levels with progression of diabetic kidney disease in patients with type 2 diabetes.
    Hanai K; Babazono T; Mugishima M; Yoshida N; Nyumura I; Toya K; Bouchi R; Tanaka N; Uchigata Y
    Diabetes Care; 2011 Dec; 34(12):2557-9. PubMed ID: 21994433
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Clinical Value of Serum Adropin Level in Early Detection of Diabetic Nephropathy.
    Es-Haghi A; Al-Abyadh T; Mehrad-Majd H
    Kidney Blood Press Res; 2021; 46(6):734-740. PubMed ID: 34644709
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Urinary IgG, serum CX3CL1 and miRNA-152-3p: as predictors of nephropathy in Egyptian type 2 diabetic patients.
    Abdou AE; Anani HAA; Ibrahim HF; Ebrahem EE; Seliem N; Youssef EMI; Ghoraba NM; Hassan AS; Ramadan MAA; Mahmoud E; Issa S; Maghraby HM; Abdelrahman EK; Hassan HAM
    Tissue Barriers; 2022 Jul; 10(3):1994823. PubMed ID: 34689723
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Which factors actually influence the development and progression of overt nephropathy in Nigerian diabetics?
    Ibrahim A; Arogundade FA; Sanusi AA; Ikem R; Akintomide AO; Akinsola AA
    Cent Afr J Med; 2009; 55(5-8):28-34. PubMed ID: 21977825
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy.
    Liu F; Guo J; Zhang Q; Liu D; Wen L; Yang Y; Yang L; Liu Z
    PLoS One; 2015; 10(10):e0141471. PubMed ID: 26517838
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Determination of RBC membrane and serum lipid composition in Trinidadian type II diabetics with and without nephropathy.
    Nayak BS; Beharry VY; Armoogam S; Nancoo M; Ramadhin K; Ramesar K; Ramnarine C; Singh A; Singh A; Nwachi KU; Teelucksing S; Mathura R; Roberts L
    Vasc Health Risk Manag; 2008; 4(4):893-9. PubMed ID: 19066007
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Association of Postbreakfast Triglyceride and Visit-to-Visit Annual Variation of Fasting Plasma Glucose with Progression of Diabetic Nephropathy in Patients with Type 2 Diabetes.
    Kitaoka K; Takenouchi A; Tsuboi A; Fukuo K; Kazumi T
    J Diabetes Res; 2016; 2016():4351376. PubMed ID: 27975066
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Increased Expression of Circulating Stress Markers, Inflammatory Cytokines and Decreased Antioxidant Level in Diabetic Nephropathy.
    Mansoor G; Tahir M; Maqbool T; Abbasi SQ; Hadi F; Shakoori TA; Akhtar S; Rafiq M; Ashraf M; Ullah I
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363561
    [No Abstract]   [Full Text] [Related]  

  • 98. Plasma concentration of soluble intercellular adhesion molecule-1 (sICAM-1) is elevated in type 2 diabetic patients, and sICAM-1 synthesis is associated with leptin-induced activation of the mitogen-activated protein kinase (MAPK) pathway.
    Cha JJ; Hyun YY; Jee YH; Lee MJ; Han KH; Kang YS; Han SY; Cha DR
    Inflammation; 2013 Aug; 36(4):878-87. PubMed ID: 23417849
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Vascular inflammation, atherosclerosis, and lipid metabolism and the occurrence of non-high albuminuria diabetic kidney disease: A cross-sectional study.
    Yang Y; Xu P; Liu Y; Chen X; He Y; Feng J
    Diab Vasc Dis Res; 2021; 18(1):1479164121992524. PubMed ID: 33567895
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Inconsistency in albuminuria predictors in type 2 diabetes: a comparison between neural network and conditional logistic regression.
    Morteza A; Nakhjavani M; Asgarani F; Carvalho FL; Karimi R; Esteghamati A
    Transl Res; 2013 May; 161(5):397-405. PubMed ID: 23333109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.